scispace - formally typeset
A

Anupam Maurya

Researcher at Central Institute of Medicinal and Aromatic Plants

Publications -  28
Citations -  506

Anupam Maurya is an academic researcher from Central Institute of Medicinal and Aromatic Plants. The author has contributed to research in topics: High-performance liquid chromatography & Ursolic acid. The author has an hindex of 12, co-authored 28 publications receiving 397 citations.

Papers
More filters
Journal ArticleDOI

Purification, characterization, and in vitro activity of 2,4-Di-tert-butylphenol from Pseudomonas monteilii PsF84: conformational and molecular docking studies.

TL;DR: To the authors' knowledge, this is the first report of antifungal VOC (2,4-di-tert-butylphenol) produced by P. monteilii that can be a potent inhibitor of β-tubulin of F. oxysporum.
Journal ArticleDOI

Antibacterial and synergy of clavine alkaloid lysergol and its derivatives against nalidixic acid-resistant Escherichia coli.

TL;DR: Treatment of Escherichia coli strains with the combinations of antibiotics and lysergol and its derivatives 10 and 11 (at reduced concentrations) significantly decreased the viability of cells, which may be of great help in antibacterial drug development from a very common, inexpensive, and non‐toxic natural product.
Journal ArticleDOI

Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistant Escherichia coli.

TL;DR: Six semi‐synthetic derivatives of ursolic acid may find their potential use as synergistic agents in the treatment of multidrug‐resistant Gram‐negative infections.
Journal ArticleDOI

Synergy of clavine alkaloid 'chanoclavine' with tetracycline against multi-drug-resistant E. coli.

TL;DR: Evaluated synergy potential and understanding the drug resistance reversal mechanism of chanoclavine isolated from Ipomoea muricata against the multi-drug-resistant clinical isolate of Escherichia coli (MDREC), and it is hypothesized that chanOClavine might be inhibiting the efflux of tetracycline from MDREC and thus enabling the more availability of tTracecline inside the cell for its action.
Journal ArticleDOI

Bioactivity guided isolation of antipsychotic constituents from the leaves of Rauwolfia tetraphylla L.

TL;DR: It was observed that MeOH extract was behaving similar to other clinically used novel atypical antipsychotics in having 5-HT(2A) occupancy greater than the DA-D(2) receptor at the tested doses.